Home > Insider Trading > Filing (0000891293-12-000039)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
891293	Cell Therapeutics Inc	CTIC	Pharmaceutical Preparations (2834)	911533912

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1198554	A James Bianco	3101 Western Avenue, Suite 600 Seattle WA 98121	Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2012-06-27	91,380	$0.00	6,134,321	No	4	A	Direct
Common Stock	Disposition	2012-06-28	135,710	$0.56	5,998,611	No	4	S	Direct
Common Stock	Disposition	2012-06-28	50,000	$0.56	5,948,611	No	4	S	Direct
Common Stock	Disposition	2012-06-29	21,000	$0.58	5,927,611	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	3	Indirect	By wife

Footnotes

As disclosed by CTIC in a Form 8-K filed on 12/1/11, CTIC granted a bonus opportunity to the reporting person that is payable in shares of CTIC stock upon the achievement of certain performance goals. The shares reported above on this Form 4 reflect the issuance of vested stock by CTIC pursuant to the award in connection with the achievement of the Pixantrone MAA Approval goal under the award.
Proceeds from the sale were primarily used to cover taxes related to the vesting of restricted stock on 6/27/2012.